Cargando…
Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the Sanguisorba Officinalis in Suppressing Hepatocellular Carcinoma
Background: Sanguisorba Officinalis L. (SO) is a well-known traditional Chinese medicine (TCM), commonly applied to treat complex diseases, such as anticancer, antibacterial, antiviral, anti-inflammatory, anti-oxidant and hemostatic effects. Especially, it has been reported to exert anti-tumor effec...
Autores principales: | Jiang, Nan, Li, Hong, Sun, Yueshan, Zeng, Jing, Yang, Fei, Kantawong, Fahsai, Wu, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969657/ https://www.ncbi.nlm.nih.gov/pubmed/33746755 http://dx.doi.org/10.3389/fphar.2021.618522 |
Ejemplares similares
-
Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and experimental investigation
por: Li, Hong, et al.
Publicado: (2022) -
Antitumor Effects of Trimethylellagic Acid Isolated From Sanguisorba officinalis L. on Colorectal Cancer via Angiogenesis Inhibition and Apoptosis Induction
por: Bai, Chongfei, et al.
Publicado: (2020) -
Rapid Profiling of Metabolites Combined with Network Pharmacology to Explore the Potential Mechanism of Sanguisorba officinalis L. against Thrombocytopenia
por: Dai, Yubei, et al.
Publicado: (2022) -
Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer
por: Zhang, Weijia, et al.
Publicado: (2022) -
TMEA, a Polyphenol in Sanguisorba officinalis, Promotes Thrombocytopoiesis by Upregulating PI3K/Akt Signaling
por: Li, Hong, et al.
Publicado: (2021)